Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA06 - Challenges in the Treatment of Early Stage NSCLC
- 13:30 - 15:00
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Florentino Hernando-Trancho, Ayten Kayi Cangir
-
+
MA06.08 - Discussant - MA06.05, MA06.06, MA06.07
14:10 - 14:20 | Presenter: Jordi Remon
- Abstract
No abstract available for this presentation
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.01 - A Phase I/II Trial of Dasatinib and Osimertinib in TKI Naïve Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
15:15 - 15:20 | Presenter: Chul Kim | Author(s): Stephen V. Liu, Jeanette Crawford, Deepa S Subramaniam, Guiseppe Giaccone
- Abstract
Loading... -
+
MA09.02 - In Vivo, Ex Vivo and Early Clinical Activity of EGFR Monoclonal Antibody and Osimertinib in EGFR Exon 20 Insertion NSCLC
15:20 - 15:25 | Presenter: Jonathan Wesley Riess | Author(s): Nicolas Floch, Philip C. Mack, Matthew J. Martin, Daniel Vang, Paul D. Smith, Darren Cross, Mingshan Cheng, James Keck, Susan Groshen, Michael Rabin, Sukhmani Padda, Geoffrey R Oxnard, Jacob Sands, Kavitha Ramchandran, Mariana Koczywas, Jeffrey A. Moscow, Pasi A Jänne, Primo N. Lara, Edward Newman, David R Gandara
- Abstract
Loading... -
+
MA09.03 - Identification of Mechanisms of Acquired Resistance to Poziotinib in EGFR Exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC)
15:25 - 15:30 | Presenter: Jacqulyne Ponville Robichaux | Author(s): Yasir Elamin, Brett Carter, Mehmet Altan, Don Lynn Gibbons, Frank Fossella, George R Simon, Vincent Lam, George Blumenschein Jr, Anne Tsao, Jonathan Kurie, Frank E Mott, Marcelo Vailati Negrao, Limei Hu, Junqin He, Monique Nilsson, Brent Roeck, Zane Yang, Vassiliki A Papadimitrakopoulou, John Victor Heymach
- Abstract
Loading... -
+
MA09.04 - Discussant - MA09.01, MA09.02, MA09.03
15:30 - 15:45 | Presenter: Juergen Wolf
- Abstract
No abstract available for this presentation
-
+
MA09.05 - Genomic Correlates of Differential Response to EGFR-Directed Tyrosine Kinase Inhibitors
15:45 - 15:50 | Presenter: Natalie Vokes | Author(s): Tom Nguyen, Christine A Lydon, Emily Chambers, Lynette M Sholl, Mizuki Nishino, Eliezer M Van Allen, Pasi A Jänne
- Abstract
Loading... -
+
MA09.06 - Adaptive Mechanisms of Resistance to Targeted Therapy in EGFR Mutant Brain Metastasis
15:50 - 15:55 | Presenter: Don X. Nguyen | Author(s): Sally Adua, Minghui Zhao, Darren Cross, Paul Smith
- Abstract
Loading... -
+
MA09.07 - Activity of Larotrectinib in TRK Fusion Lung Cancer
15:55 - 16:00 | Presenter: Anna F Farago | Author(s): Shivaani Kummar, Victor Moreno, Jyoti D Patel, Ulrik Lassen, Lee Rosen, Nora C. Ku, Michael C. Cox, Shivani Nanda, Barrett H. Childs, David M. Hyman, Alexander Drilon
- Abstract
Loading... -
+
MA09.08 - Discussant - MA09.05, MA09.06, MA09.07
16:00 - 16:15 | Presenter: Ana Vivancos
- Abstract
No abstract available for this presentation
-
+
MA09.09 - Long-Term Outcomes to Tepotinib Plus Gefitinib in Patients with EGFR-Mutant NSCLC and MET Dysregulation: 18‑Month Follow-Up
16:15 - 16:20 | Presenter: Yi-Long Wu | Author(s): Ying Cheng, Jianying Zhou, Shun Lu, Yiping Zhang, Jun Zhao, Dong-Wan Kim, Ross Soo, Sang-we Kim, Hongming Pan, Yuh-Min Chen, Chih-Feng Chian, Xiaoqing Liu, Daniel SW Tan, Rolf Bruns, Josef Straub, Andreas Johne, Jürgen Scheele, Keunchil Park, James Chih-Hsin Yang
- Abstract
Loading... -
+
MA09.10 - Comprehensive Analysis of Secondary Mutation as Resistance Mechanism to Seven MET-TKIs for MET Exon 14 Skipping in Vitro
16:20 - 16:25 | Presenter: Toshio Fujino | Author(s): Yoshihisa Kobayashi, Kenichi Suda, Takamasa Koga, Masaya Nishino, Shuta Ohara, Masato Chiba, Akira Hamada, Toshiki Takemoto, Junichi Soh, Tetsuya Misudomi
- Abstract
Loading... -
+
MA09.11 - Mechanisms of Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14 Mutant Non-Small Cell Lung Cancer
16:25 - 16:30 | Presenter: Gonzalo Recondo Jr. | Author(s): Magda Bahcall, Lynette M Sholl, Giulia Constanza Leonardi, Biagio Ricciuti, Tom Nguyen, Deepti Venkatraman, Giuseppe Lamberti, Renato Umeton, Pasi A Jänne, Mark Awad
- Abstract
Loading... -
+
MA09.12 - Discussant - MA09.09, MA09.010, MA09.11
16:30 - 16:45 | Presenter: Ravi Salgia
- Abstract
No abstract available for this presentation
-
+
EP1.15 - Thymoma/Other Thoracic Malignancies
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Thymoma/Other Thoracic Malignancies
-
+
EP1.15-28 - Survival of Thymoma Is Extensive in Latin-American Patients: Results from Over 10 Years of Experience (CLICaP-LATimus)
08:00 - 08:00 | Presenter: Oscar Gerardo Arrieta | Author(s): Luis Mas, Ana Karina Patané, Tannia Soria, Andrés Felipe Cardona, Claudio Martin, Alejandro Ruiz-Patiño, Luis Leonardo Rojas, Rossana Ruiz, Patricia Rioja, Sophia Victoria Lozano, Zyanya Lucia Zatarain Barrón, Marcelo Corassa, Helano C. Freitas, Vladmir Cláudio Cordeiro De Lima, Luis Corrales, Carolina Sotelo, July Rodriguez, Luisa Ricaurte, Jenny Ávila, Diana Mayorga, Melissa Bravo, Pilar Archila, Jorge Otero, Hernán Carranza, Carlos Vargas, Rafael Rosell, Jordi Remon
- Abstract
Loading... -
+
EP1.15-29 - Real World Characterization and Treatment of Patients with Thymic Carcinoma: Lessons from a Latin-American Study (CLICaP-LATimus)
08:00 - 08:00 | Presenter: Oscar Gerardo Arrieta | Author(s): Luis Mas, Ana Karina Patané, Tannia Soria, Andrés Felipe Cardona, Claudio Martin, Alejandro Ruiz-Patiño, Luis Leonardo Rojas, Rossana Ruiz, Patricia Rioja, Sophia Victoria Lozano, Zyanya Lucia Zatarain Barrón, Marcelo Corassa, Helano C. Freitas, Vladmir Cláudio Cordeiro De Lima, Luis Corrales, Carolina Sotelo, July Rodriguez, Luisa Ricaurte, Jenny Ávila, Melissa Bravo, Diana Mayorga, Pilar Archila, Jorge Otero, Hernán Carranza, Carlos Vargas, Rafael Rosell, Jordi Remon
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-31 - Immunosenescence Correlates with Poor Outcome from PD-(L)1 Blockade but Not Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Roberto Ferrara | Author(s): Marie Naigeon, Edouard Auclin, Boris Duchemann, Lydie Cassard, Jean Jouniaux Medhi, Lisa Boselli, Jonathan Grivel, Aude Desnoyer, Matthieu Texier, Laura Mezquita, Frank Aboubakar, Lizza Hendriks, David Planchard, CAROLINE Caramella, Jordi Remon, Maud Ngocamus, Claudio Nicotra, Claudia Proto, Sabina Sangaletti, Nathalie Chaput, Benjamin Besse
- Abstract
Loading...
-
+
MA22 - Partnering with Patients to Understand Stigma, Disparities and Values Leading to Improved Lung Cancer Care
- 15:45 - 17:15
- 9/09/2019
- Location: Amsterdam (2011)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advocacy
- Moderators:Diego Villalón, Christina Sit
-
+
MA22.05 - Assessment of Gender Differences in the Psychosocial and Economic Impact on Patients with Stage IV Non-Small Cell Lung Cancer
16:15 - 16:20 | Presenter: Pilar Garrido | Author(s): Rosario Garcia Campelo, Margarita Majem, Enric Carcereny, Dolores Isla, Jose Luis Gonzalez Larriba, Juan Coves, Javier De Castro Carpeno, Manuel Dómine, Pilar Lianes, Oscar Juan, Josefa Terrassa, Mariano Provencio, Ana Blasco, Jose Garcia, ramon Garcias De Las Peñas, Angel Artal, Jordi Remon, Silvia Catot, Enriqueta Felip, Nuria Viñolas
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.09 - Tyrosine Kinase Inhibitors' Plasma Concentration and Oncogene-Addicted Advanced Non-Small Lung Cancer (aNSCLC) Resistance
15:30 - 15:35 | Presenter: Arthur Geraud | Author(s): Laura Mezquita, Edouard Auclin, David Combarel, JULIA Delahousse, CHARLES Naltet, CECILE Jovelet, pernelle Lavaud, Anas Gazzah, LUDOVIC Lacroix, Jordi Remon, CAROLINE Caramella, David Planchard, OLIVIER Mir, ANGELO Paci, Benjamin Besse
- Abstract
Loading...